EGFR and non-small cell lung carcinoma: Clinically, Cobas EGFR Mutation Test v2, and Therascreen®EGFR Plasma RGQ are the two FDA approved real-time PCR liquid biopsy companion diagnostic assay for the detection of plasma EGFR mutations in NSCLC.